Full Name
Mei Li Ng
(not current staff)
Main Affiliation
 
 
Email
nmeili07@nus.edu.sg
 

Results 1-6 of 6 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
11-Jan-2021The role of genetic polymorphism and other factors on clopidogrel resistance (Cr) in an asian population with coronary heart disease (chd)Akkaif, MA; Daud, NAA; Sha’aban, A; Ng, ML ; Abdul Kader, MAS; Noor, DAM; Ibrahim, B
21-Mar-2020Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic targetSukocheva, OA; Furuya, H; Ng, ML ; Friedemann, M; Menschikowski, M; Tarasov, VV; Chubarev, VN; Klochkov, SG; Neganova, ME; Mangoni, AA; Aliev, G; Bishayee, A
326-Sep-2018Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cellsNg, Mei Li ; Yarla, Nagendra S; Menschikowski, Mario; Sukocheva, Olga A
41-Mar-2023Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart FailureNg, Mei Li ; Ang, Xu; Yap, Kwan Yi; Ng, Jun Jie ; Goh, Eugene Chen Howe; Khoo, Benjamin Bing Jie; Richards, Arthur Mark ; Drum, Chester Lee 
51-Oct-2021Coronary heart disease (Chd) in elderly patients: Which drug to choose, ticagrelor and clopidogrel? a systematic review and meta-analysis of randomized controlled trialsAkkaif, MA; Sha’aban, A; Daud, NAA; Yunusa, I; Ng, ML ; Sk Abdul Kader, MA; Noor, DAM; Ibrahim, B
61-Jan-2021A review of the effects of ticagrelor on adenosine concentration and its clinical significanceAkkaif, MA; Ng, ML ; SK Abdul Kader, MA; Daud, NAA; Sha’aban, A; Ibrahim, B